Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleoside analogs therapy. | |
Wang Meng-Lan; Deng Rong; Chen En-Qiang; Tao Chuan-Min; Liao Juan; Zhou Tao-You; Wang Juan; Tang Hong | |
刊名 | Clinics and research in hepatology and gastroenterology |
2018 | |
关键词 | Hepatitis B Kinetics Nucleos(t)ide analogs therapy Serum hepatitis B core-related antigen |
ISSN号 | 2210-741X |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1832894 |
专题 | 四川大学 |
作者单位 | 1.Department of laboratory medicine, West China hospital, Sichuan university, Chengdu 610041, P.R. China. Center of infectious diseases, West China hospital, Sichuan university, Chengdu 610041, P.R. China 2.Department of laboratory medicine, West China hospital, Sichuan university, Chengdu 610041, P.R. China. Electronic address: chenenqiang1983@hotmail.com. Department of laboratory medicine, West China hospital, Sichuan university, Chengdu 610041, P.R. China. Center of infectious diseases, West China hospital, Sichuan university, Chengdu 610041, P.R. China 3.Center of infectious diseases, West China hospital, Sichuan university, Chengdu 610041, P.R. China 4.Department of laboratory medicine, West China hospital, Sichuan university, Chengdu 610041, P.R. China. Electronic address: htang6198@hotmail.com. |
推荐引用方式 GB/T 7714 | Wang Meng-Lan,Deng Rong,Chen En-Qiang,et al. Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleoside analogs therapy.[J]. Clinics and research in hepatology and gastroenterology,2018. |
APA | Wang Meng-Lan.,Deng Rong.,Chen En-Qiang.,Tao Chuan-Min.,Liao Juan.,...&Tang Hong.(2018).Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleoside analogs therapy..Clinics and research in hepatology and gastroenterology. |
MLA | Wang Meng-Lan,et al."Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleoside analogs therapy.".Clinics and research in hepatology and gastroenterology (2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论